Global Health EDCTP3 JU training fellowship with return phase
The Global Health EDCTP3 JU training fellowship with return phase is a crucial program designed to enhance clinical research capacity in Sub-Saharan Africa. It aims to develop skilled researchers and innovators, fostering a robust ecosystem for addressing infectious diseases. This initiative stands out by combining international academic training with an essential return phase to ensure sustained talent retention and knowledge transfer within African countries.
Who is Funded by Global Health EDCTP3?
The Global Health EDCTP3 JU training fellowship targets various entities and individuals committed to advancing health research in specific geographical regions, particularly Sub-Saharan Africa. The program aims to achieve significant strategic impacts by strengthening local research capabilities and promoting global health equity.
What Research is Funded by EDCTP3?
The Global Health EDCTP3 JU training fellowship focuses on critical health sectors and stages of research, supporting initiatives that build capacity and foster innovation. The program outlines specific areas of interest within R&D, details eligible and ineligible costs, and targets projects at a crucial developmental stage to maximize impact.
Funding Conditions and Requirements
The Global Health EDCTP3 JU training fellowship program operates under specific conditions and requirements governing application, consortium composition, funding allocation, and other provisions. Adherence to these guidelines is crucial for applicants and beneficiaries to ensure compliance and successful project implementation.
Application Procedure
The application procedure for the Global Health EDCTP3 JU training fellowship involves a structured, two-stage submission and evaluation process. This ensures a comprehensive assessment of proposals against rigorous criteria, with clear communication of decisions to applicants.
Legal Basis of the Program
The Global Health EDCTP3 JU training fellowship program is firmly rooted in a robust legal framework derived from European Union regulations. These foundational documents provide the authority for its establishment and operation, ensuring adherence to overarching policies and financial principles.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
300,000 €
Allocated Budget:
3,500,000 €
Open Until:
Ongoing
Award Channel:
Framework Programme Call
Region:
European Union, Overseas Countries and Territories (OCTs) (Aruba, Bonaire, Curaçao, French Polynesia, French Southern and Antarctic Territories, Greenland, New Caledonia, Saba, Saint Barthélemy, Sint Eustatius, Sint Maarten, St. Pierre and Miquelon, Wallis and Futuna Islands), Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, New Zealand, North Macedonia, Norway, Serbia, Tunisia, Turkey, Ukraine, United Kingdom, Benin, Burkina Faso, Cameroon, Côte d’Ivoire, Democratic Republic of the Congo, Ethiopia, Gabon, The Gambia, Ghana, Guinea-Bissau, Guinea-Conakry, Kenya, Liberia, Malawi, Mali, Mozambique, Niger, Nigeria, Republic of the Congo, Rwanda, Senegal, Sierra Leone, Somalia, South Africa, Tanzania, Uganda, Zambia, Zimbabwe, Canada, Morocco.
Sectors:
Healthcare, Medical Technology, Pharmaceutical Industry, Research and Development, Environmental and Climate Protection, Other
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Product Development, Capacity Building, Other
Funding Provider
Program Level:
European Union
Funding Body:
Global Health EDCTP3 Joint Undertaking
Additional Partners:
Pharmaceutical companies (expected to join as beneficiaries and/or associated partners), private (profit and non-profit) entities, clinical research organisations, foundations.
Website: